Onyx Biotec Ltd.

Financial

	Onyx Biotec	Cohance Lifesciences	JB Chem & Pharma
Operational Metrics
Financials
5 yr Average ROE	14.26 %	27.26 %	19.49 %
5yr average Equity Multiplier	2.82	1.3	1.52
5yr Average Asset Turnover Ratio	0.87	0.61	0.77
5yr Avg Net Profit Margin	5.93 %	33.51 %	16.71 %
Price to Book	0.0	22.11	7.91
P/E	17.75	140.02	39.63
5yr Avg Cash Conversion Cycle	16.09 Days	70.98 Days	7.58 Days
Inventory Days	40.2 Days	76.62 Days	50.33 Days
Days Receivable	69.43 Days	42.46 Days	67.54 Days
Days Payable	87.57 Days	85.69 Days	90.39 Days
5yr Average Interest Coverage Ratio	5.06	47.81	58.81
5yr Avg ROCE	12.24 %	32.61 %	23.05 %
5yr Avg Operating Profit Margin	13.24 %	43.1 %	24.73 %
5 yr average Debt to Equity	1.2	0.09	0.07
5yr CAGR Net Profit	-1.99 %	-1.08 %	8.05 %
5yr Average Return on Assets	5.44 %	20.57 %	12.98 %
Shareholdings
Promoter Holding	65.1 %	66.41 %	47.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	6.41 %	-6.27 %
Change in Mutual Fund Holding (3 Yrs)	0.0	2.58 %	1.15 %

Business

	Onyx Biotec	Cohance Lifesciences	JB Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Sterile Water Injections 59.49 Dry Powder Injections 38.17 Dry Powder Syrup 2.25 0 Specialty Chemicals 0 CDMO 0 API 0 Formulation exported 0 Domestic formulation 0 Others 0.09	Product Wise Break-Up Sterile Water Injections 0 Domestic formulation 0 Formulation exported 0 Dry Powder Syrup 0 Contract Technical Services & Formulations 41.45 Dry Powder Injections 0 Specialty Chemicals 17.57 Contract Research & Contract Manufacturing (CRAMS) 40.98 API 0	Product Wise Break-Up Sterile Water Injections 0 Domestic Formulations 54.69 Formulations 29.72 Dry Powder Syrup 0 0 Dry Powder Injections 0 Specialty Chemicals 0 Contract Manufacturing 13.59 Active Pharmaceutical Ingredient (API) 2.0